332 related articles for article (PubMed ID: 19778486)
21. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review.
Harris HR; Terry KL
Fertil Res Pract; 2016; 2():14. PubMed ID: 28620541
[TBL] [Abstract][Full Text] [Related]
22. Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association.
Shetty C; Rizvi SMHA; Sharaf J; Williams KD; Tariq M; Acharekar MV; Guerrero Saldivia SE; Unnikrishnan SN; Chavarria YY; Akindele AO; Jalkh APC; Eastmond AK; Hamid P
Cureus; 2023 Apr; 15(4):e37266. PubMed ID: 37162768
[TBL] [Abstract][Full Text] [Related]
23. Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: A systematic review and meta-analysis.
Fazleen NE; Whittaker M; Mamun A
Diabetes Metab Syndr; 2018 Nov; 12(6):1083-1090. PubMed ID: 29789222
[TBL] [Abstract][Full Text] [Related]
24. Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?
Fanta M
Gynecol Endocrinol; 2013 Feb; 29(2):145-7. PubMed ID: 23127146
[TBL] [Abstract][Full Text] [Related]
25. Oncological repercussions of polycystic ovary syndrome.
de França Neto AH; Rogatto S; Do Amorim MM; Tamanaha S; Aoki T; Aldrighi JM
Gynecol Endocrinol; 2010 Oct; 26(10):708-11. PubMed ID: 20528205
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
[TBL] [Abstract][Full Text] [Related]
27. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
28. Polycystic ovary syndrome and endometrial carcinoma.
Hardiman P; Pillay OC; Atiomo W
Lancet; 2003 May; 361(9371):1810-2. PubMed ID: 12781553
[TBL] [Abstract][Full Text] [Related]
29. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.
Zhao L; Zhu Z; Lou H; Zhu G; Huang W; Zhang S; Liu F
Oncotarget; 2016 Jun; 7(23):33715-21. PubMed ID: 27220885
[TBL] [Abstract][Full Text] [Related]
30. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
Escobar-Morreale HF; Roldán-Martín MB
Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
[TBL] [Abstract][Full Text] [Related]
31. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
32. Polycystic ovary syndrome and endometrial cancer.
Navaratnarajah R; Pillay OC; Hardiman P
Semin Reprod Med; 2008 Jan; 26(1):62-71. PubMed ID: 18181084
[TBL] [Abstract][Full Text] [Related]
33. Polycystic ovary syndrome and metabolic syndrome.
Ali AT
Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
[TBL] [Abstract][Full Text] [Related]
34. Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis.
Zheng SH; Du DF; Li XL
Reprod Sci; 2017 May; 24(5):656-670. PubMed ID: 27798245
[TBL] [Abstract][Full Text] [Related]
35. Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.
Galazis N; Olaleye O; Haoula Z; Layfield R; Atiomo W
Fertil Steril; 2012 Dec; 98(6):1590-601.e1. PubMed ID: 22959458
[TBL] [Abstract][Full Text] [Related]
36. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?
Targher G; Rossini M; Lonardo A
Endocrine; 2016 Feb; 51(2):211-21. PubMed ID: 26024975
[TBL] [Abstract][Full Text] [Related]
37. The association between polycystic ovaries and endometrial cancer.
Pillay OC; Te Fong LF; Crow JC; Benjamin E; Mould T; Atiomo W; Menon PA; Leonard AJ; Hardiman P
Hum Reprod; 2006 Apr; 21(4):924-9. PubMed ID: 16361289
[TBL] [Abstract][Full Text] [Related]
38. The link between female infertility and cancer: epidemiology and possible aetiologies.
Meirow D; Schenker JG
Hum Reprod Update; 1996; 2(1):63-75. PubMed ID: 9079404
[TBL] [Abstract][Full Text] [Related]
39. Increased risk of ovarian and breast malignancies in women with polycystic ovary syndrome: a review article.
Chen H; Jiang Q; Yin Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):15-21. PubMed ID: 38279500
[TBL] [Abstract][Full Text] [Related]
40. Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
Loucks TL; Talbott EO; McHugh KP; Keelan M; Berga SL; Guzick DS
Fertil Steril; 2000 Sep; 74(3):547-52. PubMed ID: 10973653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
